The global psoriatic arthritis market size was estimated at USD 11.35 billion in 2024 and is projected to reach USD 19.91 billion by 2030, growing at a CAGR of 9.8% from 2025 to 2030. The new product launches, promising pipeline, a significant rise in consumer awareness, and increasing disease burden are some factor... Read More »
July 2025The Australia legal cannabis market size was estimated at USD 123.9 million in 2024 and is projected to reach USD 815.1 million by 2033, growing at a CAGR of 20.3% from 2025 to 2033. The industry is driven by growing awareness of the health benefits of cannabis and the growing legalizati... Read More »
July 2025The U.S. antibiotics market size was estimated at USD 13.77 billion in 2024 and is projected to reach USD 16.46 billion by 2030, growing at a CAGR of 3.0% from 2025 to 2030. The growing prevalence of infectious diseases is a major factor contributing to market growth. The increasing prev... Read More »
July 2025The U.S. personalized vitamins market size was estimated at USD 1.67 billion in 2024 and is projected to reach USD 5.29 billion by 2033, growing at a CAGR of 14.32% from 2025 to 2033.This growth is driven by increasing consumer awareness of health and wellness... Read More »
July 2025The U.S. anti-venom market size was estimated at USD 424.5 million in 2024 and is projected to reach USD 670.0 million by 2030, growing at a CAGR of 8.0% from 2025 to 2030. The market is expanding due to the rising incidence of venomous bites and stings, especially from snakes and insect... Read More »
July 2025The U.S. Shingles Vaccine market size was valued at USD 3.41 billion in 2024 and is projected to register a CAGR of 10.17% during 2025 - 2033. Growth in the market is primarily driven by the expanding elderly population, increased awareness of shingles-related complications, and the broa... Read More »
July 2025The U.S. acromegaly treatment market size was estimated at USD 571.3 million in 2024 and is projected to reach USD 977.2 million by 2033, growing at a CAGR of 6.2% from 2025 to 2033. This is attributed to the rising prevalence of acromegaly and earlier diagnoses, coupled with advancement... Read More »
July 2025The global antibiotics market size was estimated at USD 53.07 billion in 2024 and is projected to reach USD 74.07 billion by 2033, growing at a CAGR of 3.71% from 2025 to 2033. major factor contributing to market growth. The antibiotics market is driven by the prevalence of bacterial inf... Read More »
July 2025The global Eliquis (apixaban) market size was estimated at USD 20.70 billion in 2024 and is projected to reach USD 18.87 billion by 2033, with a decline of CAGR of -2.2% from 2025 to 2033, primarily due to loss of patent exclusivity, growing generic competition, and consequent price eros... Read More »
July 2025The U.S. lysosomal storage disease treatment market size was estimated at USD 1.41 billion in 2024 and is projected to reach USD 1.99 billion by 2033, growing at a CAGR of 4.10% from 2025 to 2033. The rising prevalence of rare genetic disorders, better diagnostic capabilities, and broader access to enzyme replacemen... Read More »
July 2025The U.S. antibody drug conjugates market size was valued at USD 7.15 billion in 2024 and is projected to reach USD 10.60 billion by 2030, growing at a CAGR of 4.9% from 2025 to 2030. This can be attributed to the increasing incidence of cancer cases and increased demand for low-tox... Read More »
July 2025The U.S. antifungal drugs market was estimated at USD 6.05 billion in 2024 and is projected to reach USD 7.20 billion by 2030, growing at a CAGR of 3.0% from 2025 to 2030. The growing incidence of fungal infections drives market expansion. Fungal infections cover a broad range of conditi... Read More »
July 2025The U.S. anti-pollution nasal spray market size was estimated at USD 2.29 billion in 2024 and is projected to reach USD 2.80 billion by 2030, growing at a CAGR of 3.4% from 2025 to 2030. Globally, high air pollution levels, driven by industrialization, urbanization, and rising vehicular ... Read More »
July 2025The U.S. longevity and general wellness supplements market size was estimated at USD 6.01 billion in 2024 and is projected to grow at a CAGR of 6.02% from 2025 to 2033. This sustained growth is driven by rising consumer awareness around preventive health, aging populations seeking to ext... Read More »
July 2025The U.S. antibiotic resistance market size was estimated at USD 3.09 billion in 2024 and is projected to reach USD 3.99 billion by 2030, growing at a CAGR of 4.4% from 2025 to 2030. The market is expected to grow, driven by the rising misuse and overuse of antibiotics. According to the C... Read More »
July 2025The U.S. antiviral drugs market size was estimated at USD 26.41 billion in 2024 and is projected to reach USD 23.61 billion by 2030, growing at a CAGR of -1% from 2025 to 2030. This decline is largely due to the waning demand for COVID-19-specific antivirals, as the number of severe COVI... Read More »
July 2025The U.S. Astaxanthin market size was estimated at USD 531.11 million in 2024 and is projected to reach USD 1,684.45 million by 2033, growing at a CAGR of 13.58% from 2025 to 2033, primarily driven by innovations in microencapsulation that enhance bioavailability. Astaxanthin, a potent ca... Read More »
July 2025The U.S. antacids market size was estimated at USD 3.00 billion in 2024 and is projected to reach USD 3.73 billion in 2030, growing at a CAGR of 3.7% from 2025 to 2030. Changing dietary habits is a key factor propelling market growth over the forecast period. Rising cases of digestive is... Read More »
July 2025The U.S. attention deficit hyperactivity disorder market size was estimated at USD 10.31 billion in 2024 and is projected to reach USD 13.88 billion by 2033, growing at a CAGR of 3.3% from 2025 to 2033. The market is primarily driven by a continuous increase in diagnosed cases, supported... Read More »
July 2025The U.S. erleada market size was estimated at USD 1.28 billion in 2024 and is projected to reach USD 2.5 billion by 2033, registering a CAGR of 7.44% from 2025 to 2033. Growth is driven by rising prostate cancer prevalence, increasing adoption of novel hormonal therapies, and favora... Read More »
July 2025